Author

Sarah E. Barnett

University of LiverpoolORCID 0000-0002-3470-7528Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrian Llewellyn HarrisiD· 1 shared Ahmed M. SalmaniD· 1 shared Alexander HandysideiD· 1 shared Anastasia C. HepburniD· 1 shared Anneliese O. SpeakiD· 1 shared Brian M. OrtmanniD· 1 shared Craig N. RobsoniD· 1 shared Esther ArnaiziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian Llewellyn HarrisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SET1B drives sustained HIF activity and disease progression in clear cell renal cell carcinoma.

Brian M. Ortmann, Tekle Pauzaite, James A.C. Bertlin, Rachel Seear, Esther Arnaiz, Lukasz W. Marzec, Alexander Handyside, Laura M. Bowker, Sarah E. Barnett, Katherine Harcourt, Salwa Lin, Ahmed M. Salman, Laura Wilson, Adrian Llewellyn Harris, Grant Duncan Stewart, , James A. Nathan

This study shows SET1B maintains HIF activity in ccRCC, correlates with disease progression, and is a target for HIF-2 inhibitors.

Cancer Research · Apr 6, 2026Peer-reviewedCancer Biology